Welcome!

News Feed Item

Medidata Reports Record Second Quarter 2014 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the second quarter of 2014 and reiterated its revenue guidance.

“Medidata’s track record of strong growth, profitability and successful innovation gives us great confidence in our future ability to grow and extend our lead in the industry,” said Tarek Sherif, Medidata's chairman and chief executive officer. “Our market opportunity is significant and we are successfully executing on our near- and long-term plan. Reflecting on Medidata’s performance this quarter, we continue to benefit from many of the same positive trends we have seen over the past 18 months, including an improving funding environment for biotechnology companies and increased focus on improving drug development efficiency. We see this reflected in increased deal activity, new customer wins and greater multi-product adoption. Our ability to innovate and expand the breadth and relevance of our platform is fueling greater interest and awareness of our solutions across the globe and is contributing to our growing pipeline of opportunities.”

Second Quarter 2014 Results

  • Total revenues for the second quarter of 2014 were $83.2 million, an increase of $15.1 million, or 22%, compared with $68.1 million in 2013. Subscription revenue was $68.9 million, an increase of 22% compared with the same period last year.
  • GAAP operating income for the quarter was $7.1 million, compared with $8.8 million in the second quarter of 2013. Non-GAAP operating income* for the second quarter of 2014 was $18.4 million, compared with $17.5 million a year ago.
  • GAAP net income for the second quarter of 2014 was $2.3 million, or $0.04 per diluted share, compared with $5.1 million, or $0.09 per diluted share, in the second quarter of 2013. Adjusted non-GAAP net income* for the second quarter of 2014 was $9.4 million, or $0.17 per diluted share, compared with $9.5 million, or $0.18 per diluted share, in the second quarter of 2013. See the non-GAAP reconciliation included in this release for full details of the non-GAAP adjustments.
  • Total cash, cash equivalents and marketable securities were $418.5 million at the end of the second quarter of 2014, an increase of $278.1 million, or 198%, compared with $140.4 million at the end of the second quarter of 2013, primarily due to net proceeds from the convertible senior notes issued during 2013 and strong cash flows over the past year.
  • Cash flow from operations was $24.1 million in the second quarter of 2014, compared with $26.2 million a year ago.

Additional Highlights

  • Medidata’s customer base grew to 437, with 30 new clients added in the second quarter of 2014, an increase of 50% over the number of new clients added in the second quarter of 2013.
  • 54% of customers had committed to multiple products at the end of the second quarter of 2014, up from 45% at the end of the second quarter of 2013.
  • Partners continue to increase their commitments to Medidata for their technology outsourcing, with 2 top CROs signing enterprise deals. Partners also extended their ability to service non-Rave solutions, with accreditations for Medidata Patient Cloud™ as well as other solutions.
  • Billings were $78 million in the second quarter of 2014, a 19% increase over the second quarter of 2013.
  • Subscription backlog for the remainder of the year as of June 30, 2014 increased to $133 million, an increase of $23 million year over year. Remaining subscription backlog does not include revenues associated with intra-year renewals of $2 million.
  • Medidata's overall revenue retention rate was nearly 100%.

“Our strong second quarter results are highlighted by solid, profitable growth, record cash collections and stellar renewal activity,” said Cory Douglas, Medidata’s chief financial officer. “I am particularly pleased with the strength of our execution and disciplined strategic investments in the quarter. Looking ahead, we see an acceleration of subscription revenue growth and record profitability in the second half of the year.”

Financial Outlook

For the full year 2014, the company expects:

  • Revenues between $340.0 and $345.0 million.
  • Professional services revenues in the mid $50.0 million range.
  • Non-GAAP operating income between $80.0 and $83.0 million. Based on current estimates, this would equate to GAAP operating income between $28.5 and $31.5 million.**
  • Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $41.0 and $44.0 million. Based on current estimates, this would equate to GAAP net income between $9.0 and $12.0 million.**
  • While changes in the stock price could change the fully diluted share count, the company is assuming 55.1 million fully diluted shares.

**The current estimated GAAP equivalents to our Non-GAAP guidance reflect the impact of approximately $5.0 million on a pre-tax basis of additional stock based compensation expenses relative to our prior outlook.

Conference Call

The company plans to host its investor conference call today at 8:00 a.m. Eastern. The investor conference call will be available via live webcast on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. To participate by telephone, domestic participants may dial 877-303-2528 and international participants may dial 847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register. Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. A replay of the conference call can be accessed until Tuesday, August 12, 2014, by dialing 800-585-8367 domestically or 404-537-3406 internationally, with the passcode 72083877. An archive of the call will also be hosted on the “Investor” section of Medidata’s web site, http://investor.mdsol.com, for a limited period of time.

About Medidata

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Cautionary Statement

Certain statements made in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve significant risks and uncertainties about Medidata Solutions, Inc. (“Medidata”), including but not limited to statements about Medidata’s forecast of financial performance, products and services, business model, strategy and growth opportunities, and competitive position. Such statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in these statements. In particular, the risks and uncertainties include, among other things, risks associated with possible fluctuations in our financial and operating results; errors, interruptions or delays in our service or our Web hosting; the financial impact of any future acquisitions; our ability to continue to release, and gain customer acceptance of, new and improved versions of our products; changes in our sales and implementation cycles; competition; our ability to retain and expand our customer base or increase new business from those customers; our ability to hire, retain and motivate our employees and manage our growth; regulatory developments; litigation; and general developments in the economy. For additional disclosure regarding these and other risks faced by the company, see disclosures contained in Medidata’s public filings with the Securities and Exchange Commission including, the “Risk Factors” section of Medidata’s Annual Report on Form 10-K for the year ended December 31, 2013. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof, and Medidata undertakes no obligation to update such statements as a result of new information.

*Non-GAAP Financial Information

Medidata provides non-GAAP operating income, net income and net income per share applicable to common stockholders data as additional information for its operating results. These measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and an adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax-affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, an adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes. Management uses these non-GAAP measures to evaluate its financial results, develop budgets, manage expenditures, and as an important factor in determining variable compensation. In addition, investors frequently have requested information from management regarding depreciation, amortization and other non-cash charges, such as share-based compensation, and management believes, based on discussions with investors, that these non-GAAP measures enhance investors’ ability to assess Medidata’s historical and projected future financial performance. While management believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of non-GAAP financial measures. One limitation of non-GAAP operating income is that it excludes depreciation and amortization, which represents the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in our business. Medidata compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to the comparable GAAP results, which are attached to this press release.

       
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(Amounts in thousands, except per share data)
Three Months Ended

June 30,

Six Months Ended

June 30,

2014 2013 2014 2013
Revenues
Subscription $ 68,947 $ 56,346 $ 132,758 $ 106,998
Professional services 14,276   11,723   27,105   24,330  
Total revenues 83,223 68,069 159,863 131,328
Cost of revenues (1)(2)
Subscription 11,221 8,949 22,307 17,974
Professional services 9,753   7,971   19,466   16,075  
Total cost of revenues 20,974 16,920 41,773 34,049
Gross profit 62,249 51,149 118,090 97,279
Operating costs and expenses:
Research and development (1) 17,311 12,105 35,100 24,010
Sales and marketing (1)(2) 20,425 16,253 41,157 30,742
General and administrative (1) 17,373   13,955   34,419   26,599  
Total operating costs and expenses 55,109   42,313   110,676   81,351  
Operating income 7,140 8,836 7,414 15,928
Interest and other (expense) income:
Interest expense (3,827 ) (27 ) (7,608 ) (45 )
Interest income 420 59 815 135
Other (expense) income, net (28 ) (10 ) 6   144  
Total interest and other (expense) income, net (3,435 ) 22   (6,787 ) 234  
Income before income taxes 3,705 8,858 627 16,162
Provision for income taxes 1,409   3,752   146   5,356  
Net income $ 2,296   $ 5,106   $ 481   $ 10,806  
Earnings per share:
Basic (3) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
Diluted (3) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Weighted average common shares outstanding:
Basic (3) 52,457 50,850 52,284 50,546
Diluted (3) 54,828 53,488 54,998 53,056
(1) Stock-based compensation expense included in cost of revenues and operating costs and expenses is as follows:
Cost of revenues $ 1,027 $ 838 $ 2,099 $ 1,325
Research and development 817 627 1,729 1,085
Sales and marketing 1,060 1,722 3,411 2,944
General and administrative 5,726   3,937   11,090   6,975  
Total stock-based compensation $ 8,630   $ 7,124   $ 18,329   $ 12,329  
(2) Amortization expense of intangible assets included in costs of revenues and operating costs and expenses is as follows:
Cost of revenues $ 111 $ 101 $ 219 $ 382
Sales and marketing 30   33   60   146  
Total amortization of intangible assets $ 141   $ 134   $ 279   $ 528  
(3) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

       
MEDIDATA SOLUTIONS, INC.
Reconciliation of GAAP Operating Income and GAAP Net Income to

Non-GAAP Operating Income and Adjusted Non-GAAP Net Income (Unaudited)

(Amounts in thousands, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2014 2013 2014 2013
Operating income:
GAAP operating income $ 7,140 $ 8,836 $ 7,414 $ 15,928
GAAP operating margins 8.6 % 13.0 % 4.6 % 12.1 %
Stock-based compensation 8,630 7,124 18,329 12,329
Depreciation and amortization 2,609 1,473 5,144 3,324
Contingent consideration adjustment (1)   60     120  
Non-GAAP operating income $ 18,379   $ 17,493   $ 30,887   $ 31,701  
Non-GAAP operating margins 22.1 % 25.7 % 19.3 % 24.1 %
Net income:
GAAP net income $ 2,296 $ 5,106 $ 481 $ 10,806
Stock-based compensation 8,630 7,124 18,329 12,329
Amortization 141 134 279 528
Contingent consideration adjustment (1) 60 120
Non-cash interest expense on convertible senior notes (2) 3,102 6,162
Tax impact on add-back items (3) (4,749 ) (2,927 ) (9,908 ) (5,191 )
Adjusted non-GAAP net income $ 9,420   $ 9,497   $ 15,343   $ 18,592  
GAAP basic earnings per share (4) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
GAAP diluted earnings per share (4) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Adjusted Non-GAAP basic earnings per share (4) $ 0.18   $ 0.19   $ 0.29   $ 0.37  
Adjusted Non-GAAP diluted earnings per share (4) $ 0.17   $ 0.18   $ 0.28   $ 0.35  
(1) Amount represents the effect of changes in fair value of contingent consideration liability.
(2) During the third quarter of 2013, we issued $287.5 million in convertible senior notes (the "Notes") with a coupon interest rate of 1.00%. Interest is paid semiannually on February 1 and August 1 over the five-year term of the notes. In connection with the Notes, we are required to recognize non-cash interest expense, including amortization of debt discount and issuance costs, in accordance with accounting guidance for convertible debt that may be settled in cash. We exclude this incremental non-cash interest expense for purposes of calculating adjusted non-GAAP net income. We believe that excluding these expenses from our non-GAAP measures is useful to investors because such incremental non-cash interest expense does not generate a cash outflow for the company and the debt issuance costs do not represent a cash outflow for the company except in the period the Notes were issued; therefore both are not indicative of our continuing operations or meaningful when comparing current results to past results.
(3) Tax impact calculated using a 40% tax rate.
(4) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

The table above presents a reconciliation of GAAP to non-GAAP operating income, net income, and net income per share applicable to common stockholders for the three and six months ended June 30, 2014 and 2013. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes.

 

   
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(Amounts in thousands, except per share data)
June 30, 2014 December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents $ 35,192 $ 22,328
Marketable securities 183,000 218,892
Accounts receivable, net of allowance for doubtful accounts of $1,231 and $1,055, respectively 61,971 45,534
Prepaid commission expense 3,495 3,615
Prepaid expenses and other current assets 14,440 13,511
Deferred income taxes 669   665  
Total current assets 298,767 304,545
Restricted cash 5,118 5,118
Furniture, fixtures and equipment, net 41,237 41,229
Marketable securities, long-term 200,283 195,105
Goodwill 15,655 15,487
Intangible assets, net 650 904
Deferred income taxes, long-term 356 345
Other assets 9,161   10,620  
Total assets $ 571,227   $ 573,353  
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 5,283 $ 7,524
Accrued payroll and other compensation 10,654 27,773
Accrued expenses and other 9,686 12,265
Deferred revenue 57,909   52,628  
Total current liabilities 83,532   100,190  
Noncurrent liabilities:
Convertible 1.00% senior notes, net 235,228 229,705
Deferred revenue, less current portion 440 1,430
Deferred tax liabilities 2,588 5,651
Other long-term liabilities 15,205   10,564  
Total noncurrent liabilities 253,461   247,350  
Total liabilities 336,993   347,540  
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $0.01 per share; 5,000 shares authorized, none issued and outstanding
Common stock, par value $0.01 per share; 100,000 shares authorized, 55,817 and 55,018 shares issued; 54,002 and 53,634 shares outstanding, respectively 558 550
Additional paid-in capital 273,664 248,336
Treasury stock, 1,815 and 1,384 shares, respectively (44,513 ) (26,414 )
Accumulated other comprehensive income (loss) 504 (199 )
Retained earnings 4,021   3,540  
Total stockholders' equity 234,234   225,813  
Total liabilities and stockholders' equity $ 571,227   $ 573,353  
 

 
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(Amounts in thousands)
Six Months Ended June 30,
2014   2013
Cash flows from operating activities:
Net income $ 481 $ 10,806
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 5,144 3,324
Stock-based compensation 18,329 12,329
Amortization of discounts or premiums on marketable securities 2,714 1,001
Deferred income taxes (3,146 ) 3,883
Amortization of debt issuance costs 639 30
Amortization of debt discount 5,523
Excess tax benefit associated with equity awards (2,648 ) (997 )
Contingent consideration adjustment 120
Provision for doubtful accounts 266 657
Changes in operating assets and liabilities:
Accounts receivable (18,328 ) 3,274
Prepaid commission expense 657 (830 )
Prepaid expenses and other current assets 1,018 1,153
Other assets 87 (78 )
Accounts payable 2,476 (900 )
Accrued payroll and other compensation (7,134 ) (2,338 )
Accrued expenses and other 5,437 1,183
Deferred revenue 3,588 (4,140 )
Other long-term liabilities 2,711   591  
Net cash provided by operating activities 17,814   29,068  
Cash flows from investing activities:
Purchase of furniture, fixtures and equipment (11,602 ) (6,761 )
Purchase of available-for-sale marketable securities (113,019 ) (78,255 )
Proceeds from sale of available-for-sale marketable securities 141,214 65,272
Net decrease in restricted cash 226   388  
Net cash provided by (used in) investing activities 16,819   (19,356 )
Cash flows from financing activities:
Proceeds from exercise of stock options 1,885 6,150
Proceeds from employee stock purchase plan 2,513
Excess tax benefit associated with equity awards 2,648 997
Payment of acquisition-related earn-out (704 ) (380 )
Repayment of obligations under capital leases (39 ) (27 )
Acquisition of treasury stock (28,058 ) (10,461 )
Repayment of notes payable (85 ) (38 )
Net cash used in financing activities (21,840 ) (3,759 )
Net increase in cash and cash equivalents 12,793 5,953
Effect of exchange rate changes on cash and cash equivalents 71 (76 )
Cash and cash equivalents - Beginning of period 22,328   32,683  
Cash and cash equivalents - End of period $ 35,192   $ 38,560  
 

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
910Telecom exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and exchanges.
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
China Unicom exhibit at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. China United Network Communications Group Co. Ltd ("China Unicom") was officially established in 2009 on the basis of the merger of former China Netcom and former China Unicom. China Unicom mainly operates a full range of telecommunications services including mobile broadband (GSM, WCDMA, LTE FDD, TD-LTE), fixed-line broadband, ICT, data communica...
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, will present an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He will expound on the industry issues he frequently came up against as an analyst, and...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
"We're bringing out a new application monitoring system to the DevOps space. It manages large enterprise applications that are distributed throughout a node in many enterprises and we manage them as one collective," explained Kevin Barnes, President of eCube Systems, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
WebRTC sits at the intersection between VoIP and the Web. As such, it poses some interesting challenges for those developing services on top of it, but also for those who need to test and monitor these services. In his session at WebRTC Summit, Tsahi Levent-Levi, co-founder of testRTC, reviewed the various challenges posed by WebRTC when it comes to testing and monitoring and on ways to overcome them.
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product, the product owner, the needs that arise at various stages of this process, and the value brought by a software development partner to the product owner as a response to these needs.
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.